Stephanie Lovell

Insider Reports History

Location
Cambridge, MA
Signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephanie Lovell:

Company Role Class Num Shares Value Price $ Report Date Ownership
TransMedics Group, Inc. Director Common Stock 4,059 $375,173 $92.43 22 May 2025 Direct
Cyclerion Therapeutics, Inc. Director Stock Option (Right to Buy) 20,000 14 Jun 2022 Direct
TransMedics Group, Inc. Director Stock Option (Right to Buy) 1,154 23 May 2024 Direct

Insider Reports Filed by Stephanie Lovell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TMDX TransMedics Group, Inc. 22 May 2025 1 $0 4 Director 23 May 2025, 18:48
TMDX TransMedics Group, Inc. 23 May 2024 2 $0 4 Director 28 May 2024, 17:30
TMDX TransMedics Group, Inc. 25 May 2023 2 $0 4 Director 30 May 2023, 16:30
TMDX TransMedics Group, Inc. 22 Nov 2022 9 -$139,602 4 Director 23 Nov 2022, 15:30
CYCN Cyclerion Therapeutics, Inc. 14 Jun 2022 1 $0 4 Director 16 Jun 2022, 20:56
TMDX TransMedics Group, Inc. 01 Jun 2022 1 $0 4 Director 06 Jun 2022, 16:29
CYCN Cyclerion Therapeutics, Inc. 24 Jun 2021 1 $0 4 Director 28 Jun 2021, 17:27
TMDX TransMedics Group, Inc. 27 May 2021 1 $0 4 Director 01 Jun 2021, 17:20